Please enable JavaScript to continue using this application.

Compare $ALXO vs $DTIL | Chartloom

Compare

$ALXO vs $DTIL

ALX Oncology Holdings Inc · Precision BioSciences Inc

ALXO

ALX Oncology Holdings Inc

DTIL

Precision BioSciences Inc

Compare $ALXO vs $DTIL

Comparing ALX Oncology Holdings Inc and Precision BioSciences Inc

ALXOALX Oncology Holdings Inc

DTILPrecision BioSciences Inc

ALXOALX Oncology Holdings Inc

Market cap

$168M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

8.7%

52W performance

-36.5%

FCF yield

-42.2%

DTILPrecision BioSciences Inc

Market cap

$173M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

80.94x

Rev growth (TTM)

3473.0%

YTD performance

63.9%

52W performance

17.9%

FCF yield

-30.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ALXO

DTIL

Detailed metrics comparison

ALXO

ALX Oncology Holdings Inc

DTIL

Precision BioSciences Inc

Market Cap

ALXO$168M

DTIL$173M

Enterprise Value

ALXO$156M

DTIL$110M

Price

ALXO$1.25

DTIL$6.72

P/E Ratio

ALXON/A

DTILN/A

P/S Ratio

ALXO46.09x

DTIL3.85x

EV/Sales

ALXO0.00x

DTIL2.44x

EV/EBITDA

ALXO0.00x

DTIL0.00x

P/B Ratio

ALXO1.24x

DTIL3.85x

P/FCF Ratio

ALXON/A

DTILN/A

EV/FCF

ALXO-2.20x

DTIL-2.09x

PEG Ratio

ALXON/A

DTILN/A

Forward P/E (NTM)

ALXON/A

DTILN/A

Forward P/S (NTM)

ALXON/A

DTIL80.94x

Revenue (TTM)

ALXO$0

DTIL$45M

Revenue Growth (YoY)

ALXON/A

DTIL3473.0%

Forward Rev Growth

ALXO357.6%

DTIL-28.2%

Gross Margin (TTM)

ALXO9.0%

DTIL0.0%

Operating Margin (TTM)

ALXO0.0%

DTIL0.0%

EBITDA Margin (TTM)

ALXO0.0%

DTIL-78.0%

Net Margin (TTM)

ALXO0.0%

DTIL-117.0%

FCF Margin (TTM)

ALXON/A

DTIL-116.3%

Net Income (TTM)

ALXO$-81M

DTIL$-53M

FCF (TTM)

ALXO$-71M

DTIL$-52M

EPS (TTM)

ALXO-$0.60

DTIL-$2.04

ROE (TTM)

ALXO-9030.0%

DTIL-9160.0%

ROA (TTM)

ALXO-6728.0%

DTIL-4074.0%

ROIC (TTM)

ALXO-8046.0%

DTIL-6594.0%

Cash

ALXO$23M

DTIL$86M

Debt

ALXO$11M

DTIL$22M

Net Cash/Debt

ALXO$12M

DTIL$64M

Current Ratio (TTM)

ALXO9.71x

DTIL12.82x

Quick Ratio (TTM)

ALXO9.44x

DTIL12.26x

Debt/Equity (TTM)

ALXO0.08x

DTIL0.50x

Debt/Assets (TTM)

ALXO0.0%

DTIL0.0%

Interest Coverage (TTM)

ALXON/A

DTILN/A

Net Debt/EBITDA (TTM)

ALXO0.00x

DTIL0.00x

Beta

ALXO0.55

DTIL1.44

52W Performance

ALXO-36.5%

DTIL17.9%

YTD Performance

ALXO8.7%

DTIL63.9%

% from 52W High

ALXO-53.0%

DTIL-30.1%

% from 52W Low

ALXO19.0%

DTIL90.4%

Asset Turnover (TTM)

ALXO0.00x

DTIL0.36x

FCF Yield (TTM)

ALXO-42.2%

DTIL-30.2%

Earnings Yield (TTM)

ALXO-48.1%

DTIL-30.4%

Dividend Yield (TTM)

ALXON/A

DTILN/A

Rule of 40

ALXO0.0

DTIL3,356.7

EV/GP/RG

ALXON/A

DTILN/A

Ticker research

View ALXO research View DTIL research

Metric	ALXO ALX Oncology Holdings Inc	DTIL Precision BioSciences Inc
Market & Valuation
Market Cap	$168M	$173M
Enterprise Value	$156M	$110M
Price	$1.25	$6.72
P/E Ratio	N/A	N/A
P/S Ratio	46.09x	3.85x
EV/Sales	0.00x	2.44x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.24x	3.85x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.20x	-2.09x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	80.94x
Revenue & Growth
Revenue (TTM)	$0	$45M
Revenue Growth (YoY)	N/A	3473.0%
Forward Rev Growth	357.6%	-28.2%
Profitability
Gross Margin (TTM)	9.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-78.0%
Net Margin (TTM)	0.0%	-117.0%
FCF Margin (TTM)	N/A	-116.3%
Net Income (TTM)	$-81M	$-53M
FCF (TTM)	$-71M	$-52M
EPS (TTM)	-$0.60	-$2.04
ROE (TTM)	-9030.0%	-9160.0%
ROA (TTM)	-6728.0%	-4074.0%
ROIC (TTM)	-8046.0%	-6594.0%
Financial Health
Cash	$23M	$86M
Debt	$11M	$22M
Net Cash/Debt	$12M	$64M
Current Ratio (TTM)	9.71x	12.82x
Quick Ratio (TTM)	9.44x	12.26x
Debt/Equity (TTM)	0.08x	0.50x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.55	1.44
52W Performance	-36.5%	17.9%
YTD Performance	8.7%	63.9%
% from 52W High	-53.0%	-30.1%
% from 52W Low	19.0%	90.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.36x
FCF Yield (TTM)	-42.2%	-30.2%
Earnings Yield (TTM)	-48.1%	-30.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	3,356.7
EV/GP/RG	N/A	N/A
Ticker research	View ALXO research	View DTIL research

Valuation

P/S Ratio

DTIL

3.85x

ALXO

46.09x

EV/FCF

ALXO

-2.20x

DTIL

-2.09x

Growth & revenue

Revenue Growth TTM

DTIL

3473.0%

Forward Revenue Growth

ALXO

357.6%

DTIL

-28.2%

Profitability & performance

Gross Margin

ALXO

9.0%

DTIL

0.0%

ROE

ALXO

-9030.0%

DTIL

-9160.0%

FCF Yield %

DTIL

-30.2%

ALXO

-42.2%

52-Week Performance

DTIL

17.9%

ALXO

-36.5%

Detailed metrics comparison

ALXO

ALX Oncology Holdings Inc

DTIL

Precision BioSciences Inc

Market Cap

ALXO$168M

DTIL$173M

Enterprise Value

ALXO$156M

DTIL$110M

Price

ALXO$1.25

DTIL$6.72

P/E Ratio

ALXON/A

DTILN/A

P/S Ratio

ALXO46.09x

DTIL3.85x

EV/Sales

ALXO0.00x

DTIL2.44x

EV/EBITDA

ALXO0.00x

DTIL0.00x

P/B Ratio

ALXO1.24x

DTIL3.85x

P/FCF Ratio

ALXON/A

DTILN/A

EV/FCF

ALXO-2.20x

DTIL-2.09x

PEG Ratio

ALXON/A

DTILN/A

Forward P/E (NTM)

ALXON/A

DTILN/A

Forward P/S (NTM)

ALXON/A

DTIL80.94x

Revenue (TTM)

ALXO$0

DTIL$45M

Revenue Growth (YoY)

ALXON/A

DTIL3473.0%

Forward Rev Growth

ALXO357.6%

DTIL-28.2%

Gross Margin (TTM)

ALXO9.0%

DTIL0.0%

Operating Margin (TTM)

ALXO0.0%

DTIL0.0%

EBITDA Margin (TTM)

ALXO0.0%

DTIL-78.0%

Net Margin (TTM)

ALXO0.0%

DTIL-117.0%

FCF Margin (TTM)

ALXON/A

DTIL-116.3%

Net Income (TTM)

ALXO$-81M

DTIL$-53M

FCF (TTM)

ALXO$-71M

DTIL$-52M

EPS (TTM)

ALXO-$0.60

DTIL-$2.04

ROE (TTM)

ALXO-9030.0%

DTIL-9160.0%

ROA (TTM)

ALXO-6728.0%

DTIL-4074.0%

ROIC (TTM)

ALXO-8046.0%

DTIL-6594.0%

Cash

ALXO$23M

DTIL$86M

Debt

ALXO$11M

DTIL$22M

Net Cash/Debt

ALXO$12M

DTIL$64M

Current Ratio (TTM)

ALXO9.71x

DTIL12.82x

Quick Ratio (TTM)

ALXO9.44x

DTIL12.26x

Debt/Equity (TTM)

ALXO0.08x

DTIL0.50x

Debt/Assets (TTM)

ALXO0.0%

DTIL0.0%

Interest Coverage (TTM)

ALXON/A

DTILN/A

Net Debt/EBITDA (TTM)

ALXO0.00x

DTIL0.00x

Beta

ALXO0.55

DTIL1.44

52W Performance

ALXO-36.5%

DTIL17.9%

YTD Performance

ALXO8.7%

DTIL63.9%

% from 52W High

ALXO-53.0%

DTIL-30.1%

% from 52W Low

ALXO19.0%

DTIL90.4%

Asset Turnover (TTM)

ALXO0.00x

DTIL0.36x

FCF Yield (TTM)

ALXO-42.2%

DTIL-30.2%

Earnings Yield (TTM)

ALXO-48.1%

DTIL-30.4%

Dividend Yield (TTM)

ALXON/A

DTILN/A

Rule of 40

ALXO0.0

DTIL3,356.7

EV/GP/RG

ALXON/A

DTILN/A

Ticker research

View ALXO research View DTIL research

Metric	ALXO ALX Oncology Holdings Inc	DTIL Precision BioSciences Inc
Market & Valuation
Market Cap	$168M	$173M
Enterprise Value	$156M	$110M
Price	$1.25	$6.72
P/E Ratio	N/A	N/A
P/S Ratio	46.09x	3.85x
EV/Sales	0.00x	2.44x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.24x	3.85x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.20x	-2.09x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	80.94x
Revenue & Growth
Revenue (TTM)	$0	$45M
Revenue Growth (YoY)	N/A	3473.0%
Forward Rev Growth	357.6%	-28.2%
Profitability
Gross Margin (TTM)	9.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-78.0%
Net Margin (TTM)	0.0%	-117.0%
FCF Margin (TTM)	N/A	-116.3%
Net Income (TTM)	$-81M	$-53M
FCF (TTM)	$-71M	$-52M
EPS (TTM)	-$0.60	-$2.04
ROE (TTM)	-9030.0%	-9160.0%
ROA (TTM)	-6728.0%	-4074.0%
ROIC (TTM)	-8046.0%	-6594.0%
Financial Health
Cash	$23M	$86M
Debt	$11M	$22M
Net Cash/Debt	$12M	$64M
Current Ratio (TTM)	9.71x	12.82x
Quick Ratio (TTM)	9.44x	12.26x
Debt/Equity (TTM)	0.08x	0.50x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.55	1.44
52W Performance	-36.5%	17.9%
YTD Performance	8.7%	63.9%
% from 52W High	-53.0%	-30.1%
% from 52W Low	19.0%	90.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.36x
FCF Yield (TTM)	-42.2%	-30.2%
Earnings Yield (TTM)	-48.1%	-30.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	3,356.7
EV/GP/RG	N/A	N/A
Ticker research	View ALXO research	View DTIL research